-
1
-
-
0029989110
-
Diabetes and cardiovascular disease in prospective population survey in Japan, the Hisayama study
-
Fujishima, M., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., Ohmori, S. & Yoshitake, T. (1996) Diabetes and cardiovascular disease in prospective population survey in Japan, the Hisayama study. Diabetes, 45, Suppl., 314-316.
-
(1996)
Diabetes
, vol.45
, Issue.SUPPL.
, pp. 314-316
-
-
Fujishima, M.1
Kiyohara, Y.2
Kato, I.3
Ohmura, T.4
Iwamoto, H.5
Nakayama, K.6
Ohmori, S.7
Yoshitake, T.8
-
2
-
-
0020617492
-
Mortality from coronary heart disease and stroke in relation to degree of glycaemia
-
The Whitehall study
-
Fuller, J.H., Shipley, M.J., Rose, G., Jarrett, R.J. & Keen, H. (1983) Mortality from coronary heart disease and stroke in relation to degree of glycaemia. The Whitehall study. Br. Med. J., 287867-287870.
-
(1983)
Br. Med. J.
, pp. 287867-287870
-
-
Fuller, J.H.1
Shipley, M.J.2
Rose, G.3
Jarrett, R.J.4
Keen, H.5
-
3
-
-
11944263528
-
Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis
-
Harris, M.I., Klein, R., Welborn, T.A. & Knuiman, M.W. (1992) Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care, 15, 815-819.
-
(1992)
Diabetes Care
, vol.15
, pp. 815-819
-
-
Harris, M.I.1
Klein, R.2
Welborn, T.A.3
Knuiman, M.W.4
-
4
-
-
0029838433
-
Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A metaanalysis of population-based prospective studies
-
Hokanson, J.E. & Austin, M.A. (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metaanalysis of population-based prospective studies. J. Cardiovascular. Risk, 3, 213-219.
-
(1996)
J. Cardiovascular. Risk
, vol.3
, pp. 213-219
-
-
Hokanson, J.E.1
Austin, M.A.2
-
5
-
-
33645440543
-
Guideline for treatment of diabetes mellitus
-
Japan Diabetes Society Tokyo. Japan. (in Japanese)
-
Japan Diabetes Society (1999) Guideline for treatment of diabetes mellitus. Tokyo. Japan. (in Japanese)
-
(1999)
-
-
-
6
-
-
0029760006
-
Insulin resistance and coronary heart disease
-
Laakso, M. (1996) Insulin resistance and coronary heart disease. Curr. Opin. Lipidol., 7, 217-226.
-
(1996)
Curr. Opin. Lipidol.
, vol.7
, pp. 217-226
-
-
Laakso, M.1
-
7
-
-
32844467923
-
Insulin resistance and metabolic syndrome contribute significantly to the transition of borderline glucose tolerance to type 2 diabetes mellitus
-
Matsumoto, K., Ozaki, M., Fujita, N. & Miyake, S. (2005) Insulin resistance and metabolic syndrome contribute significantly to the transition of borderline glucose tolerance to type 2 diabetes mellitus. Journal of the Japan Diabetes Society, 48, 849-854.
-
(2005)
Journal of the Japan Diabetes Society
, vol.48
, pp. 849-854
-
-
Matsumoto, K.1
Ozaki, M.2
Fujita, N.3
Miyake, S.4
-
8
-
-
0032080923
-
Normal triglyceride levels and coronary artery disease events: The Baltimore Coronary Observational Long Term Study
-
Miller, M., Seidler, A., Moalemi, A. & Person, T.A. (1998) Normal triglyceride levels and coronary artery disease events: The Baltimore Coronary Observational Long Term Study. J. Am. Coll. Cardiol., 31, 1252-1257.
-
(1998)
J. Am. Coll. Cardiol.
, vol.31
, pp. 1252-1257
-
-
Miller, M.1
Seidler, A.2
Moalemi, A.3
Person, T.A.4
-
9
-
-
33845366977
-
Labor and Welfare
-
Ministry of Health National Diabetes Survey
-
Ministry of Health (1997) Labor and Welfare, National Diabetes Survey.
-
(1997)
-
-
-
11
-
-
0027485431
-
Plasma lipoprotein and progression of coronary artery disease evaluated by angiography and clinical events
-
Phillips, N.R., Waters, D. & Havel, R.J. (1993) Plasma lipoprotein and progression of coronary artery disease evaluated by angiography and clinical events. Circulation, 88, 2762-2770.
-
(1993)
Circulation
, vol.88
, pp. 2762-2770
-
-
Phillips, N.R.1
Waters, D.2
Havel, R.J.3
-
12
-
-
0028961110
-
Diabetes and cardiovascular disease. The "common soil" hypothesis
-
Stern, M.P. (1995) Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes, 44, 369-374.
-
(1995)
Diabetes
, vol.44
, pp. 369-374
-
-
Stern, M.P.1
-
13
-
-
33845351231
-
Differentiation between insulin dependent diabetes mellitus (NIDDM) and insulin dependent diabetes mellitus (IDDM)
-
KYORIN Pharmaceutical Co., Ltd
-
Tajima, N. (1999) Differentiation between insulin dependent diabetes mellitus (NIDDM) and insulin dependent diabetes mellitus (IDDM). Doctor. Salon., 43, KYORIN Pharmaceutical Co., Ltd., 120-124.
-
(1999)
Doctor. Salon.
, vol.43
, pp. 120-124
-
-
Tajima, N.1
-
14
-
-
0027370108
-
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
-
The Diabetes Control and Complications Trial Research Group
-
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med., 329, 977-986.
-
(1993)
N. Engl. J. Med.
, vol.329
, pp. 977-986
-
-
-
15
-
-
0033047374
-
Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose
-
The Funagata Diabetes Study
-
Tominaga, M., Igarashi, K., Eguchi, H., Kato, T., Manaka, H. & Sekikawa, A. (1999) Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care, 22, 920-924.
-
(1999)
Diabetes Care
, vol.22
, pp. 920-924
-
-
Tominaga, M.1
Igarashi, K.2
Eguchi, H.3
Kato, T.4
Manaka, H.5
Sekikawa, A.6
-
16
-
-
0032511583
-
Intensive blood-glucose control with control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS33)
-
UK Prospective Diabetes Study (UKPDS) Group UKPDS Group
-
UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS33). UKPDS Group. Lancet, 352, 837-953.
-
(1998)
Lancet
, vol.352
, pp. 837-953
-
-
|